Lancet Oncology Review Time
The Lancet Oncology's review timeline, where delays usually happen, and what the timing means if you are preparing to submit.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
What to do next
Already submitted to The Lancet Oncology? Use this page to interpret the status and choose the next step.
The useful next step is understanding what the status usually means at The Lancet Oncology, how long the wait normally runs, and when a follow-up is actually reasonable.
Lancet Oncology inherits the Lancet family's editorial process: fast desk decisions, concurrent statistical review, and structured peer review. The timeline is comparable to the parent journal but with oncology-specific reviewer matching that can add time.
Quick answer
Lancet Oncology desk decisions arrive in 1-2 weeks (70-80% rejected). Papers entering review get first decisions in 6-10 weeks. The concurrent in-house statistical review adds rigor but not significant additional time. Total from submission to acceptance runs 4-7 months including revision.
Lancet Oncology review timeline
Stage | Typical timing | What is happening |
|---|---|---|
Initial screening | 1-3 days | Format compliance, basic scope |
Editorial triage | 1-2 weeks | Senior editors assess clinical oncology significance |
Statistical review | Concurrent with peer review | In-house statisticians evaluate methodology |
Peer review | 4-6 weeks | 2-3 clinical oncology reviewers |
First decision | 6-10 weeks from submission | Accept, revise, reject, or redirect to Lancet family |
Revision window | 4-6 weeks | Must address clinical, statistical, and reviewer concerns |
Post-revision | 3-5 weeks | May return to reviewers |
What makes Lancet Oncology's process different from JCO
JCO and Lancet Oncology both review clinical oncology, but the process differs:
In-house statistical review: Lancet Oncology has dedicated statisticians who evaluate methodology concurrently with peer review. JCO relies more on reviewer-provided statistical assessment. This means Lancet Oncology's first decision is more comprehensive but can take slightly longer.
Research in Context requirement: The structured panel forces authors to articulate clinical implications upfront, which helps editors triage faster. JCO doesn't require this format.
Lancet family cascade: If Lancet Oncology editors see merit but not flagship-level importance, they may offer to redirect within the Lancet family (Lancet Regional Health, eClinicalMedicine, etc.).
When to follow up
Situation | What to do |
|---|---|
No desk decision after 3 weeks | Unusual. Polite inquiry appropriate. |
Under review for 8+ weeks | Normal upper range. |
Under review for 12+ weeks | Follow up. Oncology reviewer recruitment can be slow. |
Should you submit?
Submit if:
- the clinical oncology evidence could change practice guidelines globally
- the Research in Context panel writes itself
- you're comfortable with the Lancet family's structured review process
Think twice if:
- JCO's broader scope and faster process is a better practical fit
- the finding is primarily cancer biology (Cancer Cell is the better home)
- the evidence level won't survive in-house statistical scrutiny
A free manuscript scan can help assess whether the clinical framing meets Lancet Oncology's editorial threshold.
FAQ
How long does Lancet Oncology take to desk-reject?
Typically 1-2 weeks. 70-80% of submissions are desk-rejected.
How long does Lancet Oncology peer review take?
4-6 weeks for reviewer reports, 6-10 weeks total to first decision.
Does Lancet Oncology transfer papers within the Lancet family?
Yes. Editors may offer redirects to other Lancet journals if the paper has merit but doesn't meet the flagship threshold.
Sources
- Clarivate Journal Citation Reports (released June 2025)
- Lancet Oncology information for authors
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Best next step
Use this page to interpret the status and choose the next sensible move.
For The Lancet Oncology, the better next step is guidance on timing, follow-up, and what to do while the manuscript is still in the system. Save the Free Readiness Scan for the next paper you have not submitted yet.
Guidance first. Use the scan for the next manuscript.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Lancet Oncology Submission Process: What Happens After You Upload
- How to Avoid Desk Rejection at Lancet Oncology
- Lancet Oncology Acceptance Rate 2026: How Selective Is It?
- Lancet Oncology Impact Factor 2026: 35.9, Rank 8/326, and What It Means
- Is Lancet Oncology a Good Journal? Fit Verdict
- How to Submit to Lancet Oncology: Complete Guide
Supporting reads
Use this page to interpret the status and choose the next sensible move.
Guidance first. Use the scan for the next manuscript.